BIOMAT Database Logo BIOMAT Database Logo

[Bactericidal effect of rifampicin on resting tubercle bacilli in vitro (author's transl)]. 1979

K Kanai, and E Kondo

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

K Kanai, and E Kondo
[Rifampicin treatment for pulmonary tuberculosis--effectiveness of rifampicin on tubercle bacilli in pulmonary lesions (author's transl)].
July 1975, Kekkaku : [Tuberculosis],
K Kanai, and E Kondo
Methods for determining the bactericidal effect of active substances on tubercle bacilli (transl.)
May 1949, "Laboratorio;" analisis clinicos, bacteriologia, inmunologia, parasitologia, hematologia, anatomia patologica, quimica clinica,
K Kanai, and E Kondo
[Influence of schizophyllan, streptomycin and rifampicin on histopathological changes in mice infected with tubercle bacilli (author's transl)].
August 1975, The Japanese journal of antibiotics,
K Kanai, and E Kondo
The bactericidal effect of surface-active agents on tubercle bacilli.
December 1950, Public health reports (Washington, D.C. : 1896),
K Kanai, and E Kondo
[Long term effect of isonicotinic acid hydrazid and streptomycin on resting tubercle bacilli in vitro].
January 1960, Beitrage zur Klinik der Tuberkulose und spezifischen Tuberkulose-Forschung,
K Kanai, and E Kondo
The effect of cycloserine on growing and resting tubercle bacilli.
November 1955, American review of tuberculosis,
K Kanai, and E Kondo
The effect of isoniazid on growing and resting tubercle bacilli.
January 1954, American review of tuberculosis,
K Kanai, and E Kondo
A study of chemotherapeutics on tubercle bacilli. A study of the bacteriostatic and bactericidal activity of chemotherapeutics on tubercle bacilli in vitro.
December 1950, The science reports of the research institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku,
K Kanai, and E Kondo
The Bactericidal Action of Light on Tubercle Bacilli.
July 1927, British medical journal,
K Kanai, and E Kondo
[Mycobacteriocin typing of human type tubercle bacilli (author's transl)].
January 1977, Kekkaku : [Tuberculosis],
Copied contents to your clipboard!